Trade association focused on the advancement of #lifesciences, #biotech, #pharma, and #medicaldevice in Virginia.
Joined September 2008
- Tweets 9,806
- Following 721
- Followers 3,628
- Likes 1,122
825 Photos and videos
Jun 8
🚀 Registration is open for the 12th Annual BHCR Week!
Join biohealth leaders from across the region Sept. 15-17 for collaboration, innovation, investment, and growth. Plus, applications are now open for the Crab Trap Competition!
đź”— Register today: bit.ly/43Xal6a
14
Jun 3
🎉 Congratulations to our #THRiVE2026 survey winners, who have received complimentary registration to a future VA Bio event!
Thank you to everyone who attended and shared feedback.
📸 Relive THRiVE through the photo gallery: bit.ly/4399mzB
18
Jun 1
NEW! In @CardinalNewsVA, learn more from @HarryGewanter about how #340B has run off course and drives up costs for families in VA. @RepMGriffith is right to demand answers and hold hospitals accountable for how billions in 340B savings are being used. ➡️ bit.ly/4tYQWML
4
1
130
May 28
🎉Welcome new Virginia Bio members: PILMA, Glen Research, Nexus CMC Advisors, and S1P Therapeutics Inc. Excited to have them join our life sciences community and advance innovation together.
#WelcomeNewMembers #LifeSciences #Innovation #Community
19
May 21
🎉 Congratulations to Scott Meza and Nikki Hastings, recipients of VA Bio’s 2026 Outstanding Contributions to Bioscience Award!
It was an honor to recognize their leadership and impact on Virginia’s life sciences ecosystem at #THRiVE2026 🧬
Read more: bit.ly/4wHpoxX
27
May 19
Thank you @GovernorVA for vetoing SB271/HB483 and protecting patient access to medicines while supporting VA's life sciences economy! Virginia must continue fostering innovation, investment and patient-centered healthcare solutions that increase access and reduce patient costs.
19
May 1
NEW! In @VirginianPilot, VA Bio CEO John Newby thanks @MarkWarner for co-sponsoring the PBM Price Transparency and Accountability Act — a meaningful step toward lower health care costs and greater accountability for Virginia patients. Read more: bit.ly/4d1ce67
41
Apr 17
Virginia Bio applauds @GovernorVA for rejecting a rushed government price-setting scheme in SB271/HB483. By requiring the federal MFP provisions to be re-enacted in 2027, her amendment blocks harmful price caps from taking effect in Virginia.
1
70
Apr 16
3 - 2 - 1 - NETWORK! 🚀
Registered THRiVE 2026 attendees get early access to a private networking link to start connecting before the event.
đź“… April 30
📍 Capital One – West Creek Commons
đź”—bit.ly/4s1RgLb
#THRiVE2026 #VirginiaBio #LifeSciences
31
Apr 3
Attending THRiVE 2026? Don’t forget to book your hotel.
The discounted room block at the Hilton Richmond Hotel & Spa/Short Pump closes April 7.
#THRiVE2026 #VirginiaBio #LifeSciences
42
Apr 1
NEW! In @RTDNEWS, CEO John Newby explains why the Affordable Medicine Act won’t make drugs more affordable for Virginians and could actually put critical treatments out of reach. To protect Virginia patients, @GovernorVA must veto this legislation ➡ bit.ly/3PFlIfi
76
Mar 23
MUST READ! @Mercatus experts discuss how #SB271 could stifle growth of our leading biotechnology industry – without lowering patient #OOP costs. @GovernorVA must protect VA workers and patients and oppose this bill. More in @RealClearHealth: bit.ly/4lJvB7v
1
49
Mar 12
In @CBS6, CEO John Newby highlights how the amended #SB271 could limit patient access to prescribed treatments and harm the Commonwealth’s growing life science sector. Price controls, whether at the state or federal level, are never the answer. bit.ly/4boIgbq
52
Mar 12
In @8NEWS, CEO John Newby highlights how a #PDAB would undermine continued life sciences growth here in the Commonwealth. There is no evidence that a #PDAB is effective at lowering patients' costs. Watch now ➡ wric.com/news/politics/capit…
46
Mar 11
The Virginia General Assembly is putting patients first by moving forward to study the #340B program. Before expanding this little-known program, it’s critical that our lawmakers understand who it really benefits. More in @RTDNews from @MedicareMeddler: bit.ly/4uoPZis
75
Mar 10
In @WDBJ7, CEO John Newby highlights how a #PDAB could make it harder for VA patients to access lifesaving care and limit investment in our growing biotech industry. SB 271 is not the answer for Virginia patients. See more ➡ bit.ly/4lkzGz3
1
73
Mar 10
Early bird savings for BIO International Convention 2026 are ending soon!
Register by March 26 to save up to $550. This is the lowest registration rate for 2026, and prices increase after March 26.
đź”— Secure your spot and savings now: bit.ly/4llSNbG
27
Mar 6
Less than 2 months until THRiVE 2026!
Thank you to our amazing sponsors: Catalyst, VEDP, GMU, VIPC, VWR, DPR, Greenberg Traurig, ATCC, and Goochland County Economic Development.
Register now: bit.ly/4s1RgLb
#THRiVE2026 #ThankYouSponsors #LifeSciences #VirginiaBio
27
Mar 3
In a new @VirginiaMercury article, CEO John Newby explains why a VA stakeholder working group on the #340B program will help ensure 340B is serving vulnerable patients as intended. Keep reading: bit.ly/4skj64z
42
Feb 28
1 in 10 Americans lives with a rare disease — and most still have no approved treatment. This #RareDiseaseDay, Virginia Bio stands with those who depend on medical innovation. Let’s protect the research ecosystem making breakthroughs possible. rarediseaseday.org/
51